Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions

ClinicalTrials.gov ID: NCT00067080

Public ClinicalTrials.gov record NCT00067080. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 5:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open Label, Phase II Study on Safety and Efficacy of Long Term Treatment of ICL670 Relative to Deferoxamine in Sickle Cell Disease Patients With Transfusional Hemosiderosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if the new orally active iron chelator, ICL670, is as safe as deferoxamine in preventing accumulation of iron in the body while a patient is undergoing repeated blood transfusions.

Study identification

NCT ID
NCT00067080
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
195 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2003 (Type not available)
Primary completion
Jul 2007 (Actual)
Completion
Not listed
Last update posted
Aug 22, 2017

Started 2003

United States locations

U.S. sites
34
U.S. states
17
U.S. cities
28
Facility City State ZIP Site status
U. of S. Alabama Medical Center Mobile Alabama 36604 —
Loma Linda University Medical Center Loma Linda California 92354 —
Children's Hospital Los Angeles Los Angeles California 90027 —
Children's Hospital & Research Center Oakland California 94609 —
Colorado Sickle Cell Treatment and Research Center Denver Colorado 80262 —
Howard University Hospital Washington D.C. District of Columbia 20059 —
Tampa Children's Hospital at St Joseph's Tampa Florida 33607 —
Georgia Comprehensive Sickle cell Center, Grady Hospital Atlanta Georgia 30335 —
Adult Sickle Cell Clinic, Medical College of Georgia Augusta Georgia 30912 —
University of Illinois at Chicago Chicago Illinois 60612 —
Children's Memorial Hospital Chicago Illinois 60614 —
Tulane University Sickle Cell Center New Orleans Louisiana 70112 —
Children's Hospital, Department of Hematology/Oncology New Orleans Louisiana 70118 —
Children's Hospital Boston, Division of Hematology/Oncology Boston Massachusetts 02115 —
Boston Medical Center Boston Massachusetts 02118 —
Karmanos Cancer Institute Detroit Michigan 48201 —
NY Methodist Hospital Brooklyn New York 11215 —
Weill Medical College of Cornell University New York New York 10021 —
U. Of Rochester Medical Center Rochester New York 14642 —
Sickle Cell Center, Montefiore Hospital The Bronx New York 10467 —
Wake Forest University School of Medicine Winston-Salem North Carolina 27106 —
Barrett Center, University of Cincinnati Cincinnati Ohio 45219 —
Children's Hospital Medical Center Cincinnati Ohio 45229 —
James Cancer Hospital Columbus Ohio 43210 —
Penn State Milton S Hershey Medical Center Hershey Pennsylvania 17033 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15213 —
Liberty Hematology Oncology Center Columbia South Carolina 29203 —
Palmetto Health Clinical Trials Columbia South Carolina 29203 —
Santee Hematology/Oncology Sumter South Carolina 29150 —
Baylor College of Medicine Houston Texas 77030 —
Texas Children's Hospital/Baylor College of Medicine Houston Texas 77030 —
Scott and White Memorial Hospital & Clinics Temple Texas 76508 —
Children's Hospital of the King's Daughter Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00067080, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 22, 2017 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00067080 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →